In this interview, Dr. Linlin Zhang, technical specialist for Sino Biological Europe, discusses how Sino is expanding its product offerings into the European market and outlines its process for developing and manufacturing custom recombinant antibodies for their clients.
Sino Biological produces a range of reagents for therapeutic targets of neurodegenerative diseases. This includes the growth factors GDNF, NGF, BDNF, and more.
28.03.2022 - Beijing, China, March 28, 2022 (GLOBE NEWSWIRE) - via NewMediaWire - Sino Biological, Inc.(“Sino Biological” or the “Company”), a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), which .
Sino Biological’s CRO arm can produce a custom recombinant antibody to fulfill any requirements. Their services are efficient, reliable, and have high validity.